RESUMO
A western blot (WB) test was evaluated for detection of antibodies against native glycosylated and chemically deglycosylated M and H antigens of Histoplasma capsulatum in serum obtained from patients during the acute phase of pulmonary histoplasmosis that occurred during an outbreak. Of 275 serum samples tested by immunodiffusion and complement fixation (CF) samples from 40 patients affected during this outbreak and from 37 negative controls were tested by WB test. A group of patients whose sera were negative for CF antibodies and precipitins early in the acute stage of histoplasmosis but who all seroconverted during convalescence 6 weeks later were tested with the WB test. Antibodies against untreated H and M antigens were detected at a 1:100 dilution by WB test in 45% of the 20 acute-phase serum samples and in all 20 of the convalescent-phase specimens. The WB test's sensitivity for acute-phase specimens increased to 90% (18 of 20 specimens) when H and M antigens were treated by periodate oxidation to inactivate susceptible carbohydrate epitopes. When native glycosylated antigens were used in the WB test, positive reactions were observed in negative control serum specimens (3 of 37 specimens; 8%) and in serum specimens obtained from asymptomatic persons screened as part of the outbreak investigation (13 of 20 specimens; 65%). These positive reactions were also attributed to glycosidic epitopes since the specificity of the WB test increased from 78 to 100% when periodate-treated H and M antigens were used. WB test with deglycosylated H and M antigens of histoplasmin provides a rapid, sensitive, and specific test to diagnose acute pulmonary histoplasmosis before precipitins can be detected.
Assuntos
Western Blotting/métodos , Surtos de Doenças , Histoplasmose/diagnóstico , Histoplasmose/epidemiologia , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/epidemiologia , Doença Aguda , Anticorpos Antifúngicos/sangue , Antígenos de Fungos/química , Western Blotting/estatística & dados numéricos , Estudos de Casos e Controles , Testes de Fixação de Complemento/estatística & dados numéricos , Epitopos/química , Estudos de Avaliação como Assunto , Glicosilação , Histoplasma/imunologia , Histoplasmina/química , Histoplasmose/imunologia , Humanos , Imunodifusão/estatística & dados numéricos , Pneumopatias Fúngicas/imunologia , Prisões , Sensibilidade e Especificidade , Virginia/epidemiologiaRESUMO
Introducción: El empleo de un antígeno parcialmente purificado denominado complejo polisacárido-proteína desproinizado de Histoplasma capsulatum (CPPD-Histo), utilizado para discriminar la histoplasmosis de diversas micosis pulmonares y otras enfermedades respiratorias en métodos inmunodiagnósticos de alta sensibilidad, ha sido motivo de estudio desde hace años por nuestro grupo de investigación: Objetivo: En este trabajo se planteó conocer la ubicación celular preferencial del antígeno CPPD-Histo, en las diferentes formas y estructuras de las fases micelial y levaduriforme del hongo. Material y métodos: El estudio se desarrolló mediante inmunolocalización con marcaje de oro coloidal para microscopia electrónica, usando anticuerpos primarios CPPD-Histo específicos. Resultados y discusión: La localización en microscopia electrónica mostró mayor concentración del CPPD-Histo en las zonas de mayor grosor de la capa externa de la pared celular de las proyecciones digitiformes de macroconidios, poco marcaje en pared celular de hifas, y una distribución dispersa de la marca en las levaduras. Conclusión: La pared celular de los macroconidios de la fase micelial del hongo es la estructura fúngica con mayor concentración del antígeno CPPD-Histo
Assuntos
Complexo Antígeno-Anticorpo , Coloide de Ouro , Histoplasma/imunologia , Histoplasma/ultraestrutura , Histoplasmina , Histoplasmina/química , Histoplasmina/imunologia , Micelas , Microscopia Eletrônica , Relação Estrutura-Atividade , Testes Imunológicos/métodosRESUMO
Cation exchange chromatography was evaluated to purify the M antigen from histoplasmin (HMIN). Two H and M antigen-containing fractions, soluble (S) and precipitate (PP), resulted from the initial 0.025 M, pH 3.5 citrate buffer dialysis step. The PP fraction contained 62% of the M antigen activity and was resolubilized. Both fractions were chromatographed on CM Sepharose CL-6B. Polysaccharide C antigen was abundant in the S fraction and most of it did not bind to CM Sepharose. M antigen-enriched fractions were eluted with 0.5 M NaCl. Re-chromatography of the relevant S fraction (S-II) and PP fraction (PP-II) by linear gradient fast protein liquid chromatography (FPLC) removed protein and C impurities. M antigen purified by FPLC from the PP-II fraction was depleted of other antigens when Western blots were probed with anti-M, anti-H and anti-C monoclonal antibodies (Mabs). M antigen was identified as a 94 kDa glycoprotein containing a specific-protein epitope and an epitope that reacted with a Mab against the polysaccharide C antigen. M antigen can be purified from HMIN by tandem cation exchange chromatography of the precipitable fraction on an open CM Sepharose CL-6B column followed by linear gradient FPLC.